By sharing stories and
statistics the Global Psoriasis Atlas is putting the focus on psoriasis.
The Global Psoriasis Atlas is the first database documenting
the prevalence of psoriasis around the world. This exciting piece of research
means that for the first time, experts and people living with psoriasis can gain
a better understanding of how the condition is mapped globally.
The interactive database has been formed from a
collaboration between three leading worldwide organisations, the International
Federation of Psoriasis Associations (IFPA), the International League of
Dermatological Societies (ILDS) and the International Psoriasis Council (IPC),
and is supported by work undertaken at the University of Manchester and
University Medical Center Hamburg-Eppendorf.
The online platform brings together the latest data and
compelling insights into psoriasis to present a global picture of the incidence
of the condition and the various treatments that are available across the globe.
It will be a valuable source of information for researchers, policy makers,
healthcare providers, and people with psoriasis to gain a greater understanding
of the condition.
Although mystery still surrounds psoriasis, significant progress
has been made to further our understanding of the common immune-mediated skin
condition. Research has shown that prevalence of psoriasis varies according to
genetic background and geographic location, therefore, the atlas represents a
novel opportunity to explore and compare the way in which psoriasis occurs in
different groups of people across various environments.
The atlas will also help to raise awareness of the treatment
options that are available for psoriasis worldwide, and plays host to valuable
healthcare data which enables the comparison of the quality of care in
different countries, such as the number of dermatologists working in the field.
Videos of people speaking about living with psoriasis are
also included and provide a rich backdrop to the data, highlighting the
similarities and differences between patient experiences of psoriasis in
different countries including Taiwan, Malaysia and the UK.
At present the understanding of the prevalence of psoriasis
is limited in many countries, but the Global Psoriasis Atlas is due to
radically transform this in the future, and aim to uncover the true burden of
the condition, with the goal of ensuring that those living with psoriasis have
access to the best available care, wherever they live in the world.
To explore the Global
Psoriasis Atlas visit www.globalpsoriasisatlas.org